위체류 약물전달 시스템 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Gastroretentive Drug Delivery Systems Market size is expected to reach USD 37.63 Billion in 2034 from USD 20.83 Billion (2025) growing at a CAGR of 6.79% during 2026-2034.

The global gastroretentive drug delivery systems market is witnessing strong growth due to increasing demand for improved drug absorption and targeted delivery. These systems are designed to prolong the retention of drugs in the stomach, enhancing their bioavailability and effectiveness. The rising prevalence of chronic diseases and the need for efficient drug delivery solutions are driving market expansion. Additionally, advancements in pharmaceutical technologies are supporting the development of innovative delivery systems.

Key growth drivers include the growing focus on patient compliance and controlled drug release. Gastroretentive systems help reduce dosing frequency and improve therapeutic outcomes. The increasing investment in pharmaceutical research and development is also contributing to market growth. Furthermore, the expansion of the global pharmaceutical industry and the rising demand for advanced drug formulations are supporting market development.

In the future, the gastroretentive drug delivery systems market is expected to grow significantly with continuous innovation in drug delivery technologies. The development of novel formulations and materials will further enhance performance. Emerging markets are anticipated to provide substantial growth opportunities due to increasing healthcare access. Additionally, advancements in personalized medicine will drive the adoption of targeted drug delivery solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Floating Drug Delivery System
• Expandable Drug Delivery System
• Bioadhesive Drug Delivery System
• High Density Systems
• Others

By Dosage

• Tablets
• Capsule
• Gel
• Liquid
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Catalent Inc, Lonza, Evonik Industries AG, Colorcon, Quotient Sciences, AptarGroup Inc, Aenova Holding GmbH, Evotec SE, Vectura Group Ltd, Ashland
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Floating Drug Delivery System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Expandable Drug Delivery System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Bioadhesive Drug Delivery System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. High Density Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET: BY DOSAGE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Dosage
• 5.2. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Capsule Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Liquid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Dosage
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Dosage
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Dosage
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Dosage
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Dosage
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Catalent Inc
  • 9.2.2 Lonza
  • 9.2.3 Evonik Industries AG
  • 9.2.4 Colorcon
  • 9.2.5 Quotient Sciences
  • 9.2.6 AptarGroup Inc
  • 9.2.7 Aenova Holding GmbH
  • 9.2.8 Evotec SE
  • 9.2.9 Vectura Group Ltd
  • 9.2.10 Ashland